Helping tackle hard-to-heal wounds

Oxyzyme uses advanced biochemistry to create a moist barrier that actively transports dissolved oxygen into the wound, but which remains impassable to bacteria. The overall effect is to enable epithelialisation and prevent premature scabbing.

Company founder Professor Paul Davis is particularly excited at the potential of this latest product development. “Early indications have shown Oxyzyme to be particularly effective in tackling hard-to-heal wounds,” he commented. “We believe that it will provide significant and tangible improvements in wound care.”